» Articles » PMID: 17216302

Pyridoxal 5'-phosphate May Be Curative in Early-onset Epileptic Encephalopathy

Overview
Publisher Wiley
Date 2007 Jan 12
PMID 17216302
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Neonatal epileptic encephalopathy can be caused by inborn errors of metabolism. These conditions are often unresponsive to treatment with conventional antiepileptic drugs. Six children with pyridox(am)ine-5'-phosphate oxidase (PNPO) deficiency presented with neonatal epileptic encephalopathy. Two were treated with pyridoxal 5'-phosphate (PLP) within the first month of life and showed normal development or moderate psychomotor retardation thereafter. Four children with late or no treatment died or showed severe mental handicap. All of the children showed atypical biochemical findings. Prompt treatment with PLP in all neonates and infants with epileptic encephalopathy should become mandatory, permitting normal development in at least some of those affected with PNPO deficiency.

Citing Articles

Metabolic pathways and genes involved in treatable and non-treatable metabolic epilepsies. A comprehensive review and metabolic pathway analysis.

Sesse A, Ladias P, Kostoulas C, Chatzistefanidis D, Georgiou I, Markoula S Metab Brain Dis. 2025; 40(3):152.

PMID: 40085371 DOI: 10.1007/s11011-025-01562-5.


Pyridoxal 5'-Phosphate Biosynthesis by Pyridox-(am)-ine 5'-Phosphate Oxidase: Species-Specific Features.

Rivero M, Novo N, Medina M Int J Mol Sci. 2024; 25(6).

PMID: 38542149 PMC: 10969823. DOI: 10.3390/ijms25063174.


Epilepsy Phenotypes of Vitamin B6-Dependent Diseases: An Updated Systematic Review.

Mastrangelo M, Gasparri V, Bernardi K, Foglietta S, Ramantani G, Pisani F Children (Basel). 2023; 10(3).

PMID: 36980111 PMC: 10047402. DOI: 10.3390/children10030553.


carrying epilepsy-associated variants in the vitamin B6 metabolism gene display allele- and diet-dependent phenotypes.

Chi W, Iyengar A, Fu W, Liu W, Berg A, Wu C Proc Natl Acad Sci U S A. 2022; 119(9).

PMID: 35217610 PMC: 8892510. DOI: 10.1073/pnas.2115524119.


Prognostic Implication and Oncogenic Role of PNPO in Pan-Cancer.

Zhang L, Li X, Zhang J, Xu G Front Cell Dev Biol. 2022; 9:763674.

PMID: 35127701 PMC: 8814662. DOI: 10.3389/fcell.2021.763674.


References
1.
Plecko B, Stockler-Ipsiroglu S, Paschke E, Erwa W, Struys E, Jakobs C . Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Ann Neurol. 2000; 48(1):121-5. View

2.
Wang H, Kuo M, Chou M, Hung P, Lin K, Hsieh M . Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy. Arch Dis Child. 2005; 90(5):512-5. PMC: 1720393. DOI: 10.1136/adc.2003.045963. View

3.
Brautigam C, Hyland K, Wevers R, Sharma R, Wagner L, Heitmann F . Clinical and laboratory findings in twins with neonatal epileptic encephalopathy mimicking aromatic L-amino acid decarboxylase deficiency. Neuropediatrics. 2002; 33(3):113-7. DOI: 10.1055/s-2002-33673. View

4.
Mills P, Surtees R, Champion M, Beesley C, Dalton N, Scambler P . Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase. Hum Mol Genet. 2005; 14(8):1077-86. DOI: 10.1093/hmg/ddi120. View

5.
HUNT Jr A, STOKES Jr J, McCrory W, STROUD H . Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics. 1954; 13(2):140-5. View